Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Adherence to antidepressant treatment guidelines in France: A five-year nationwide cohort study
Chloé Saint-Dizier1, Aurélie Lescroart2, Florian Dufrenois3
1Fédération régionale de recherche en psychiatrie et santé mentale (F2RSM Psy), Hauts-de-France, Saint-André-Lez-Lille, France; Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des Technologies de santé et des Pratiques médicales, Lille, France.
Purpose:
The objective of our study was to assess whether the initial antidepressant deliveries in France from 2017 to 2021 adhered to current guidelines regarding the types of antidepressants prescribed and the duration of treatment.
Methods:
We conducted a retrospective cohort study using the French national health insurance database. Antidepressant prescriptions dispensed between January 1, 2016, and December 31, 2023, were extracted. A gap in a sequence of antidepressant treatments was defined as an interval of more than 56 days between two successive dispensations.
Results:
Guideline recommendations were generally followed for the choice of antidepressant class. However, only 27.5% of sequences had durations within the recommended range of 9 to 24 months. Introducing the continuity criterion reduces the proportion of sequences adhering to the recommendations to only 4.1%.
Conclusion:
These results align with existing literature, underscoring the need to encourage adherence to guidelines, particularly concerning treatment duration, to help prevent recurrence of depressive episodes.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Therapeutic Drug Monitoring: Affecting Factors
Acute Coronary Syndrome IV: Interprofessional Care

